BioPorto launches the first human NGAL monomer specific assay.Read more
An expansion of BioPorto Diagnostics extensive NGAL portfolio with 6 new Recombinant NGAL Antigens Read more
The molecular forms of NGAL is a hot topic amongst NGAL researches these days.Read more
Sepsis frequently results in acute kidney injury (AKI). Although AKI markedly contributes to mortality in sepsis, its diagnosis is frequently delayed due to limitations of current biomarkers of renal impairment. Neutrophil-gelatinase-associated lipocalin (NGAL) has been demonstrated to be a biomarker of early AKI.
To download as pdf please click hereRead more